Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absent, Acceleron, Accountingwhich, ACCP, Acorda, ACP, acute, Adimab, admission, adult, AECOPD, Aimmune, airflow, Alector, American, Amgen, Amit, analyzed, antifungal, ARCH, Arena, Army, arose, Arsenal, Arthur, ASUNo, avium, background, Ball, Bentley, BioPharma, Boulder, Brigham, BS, BTIG, Burr, BWH, Bybee, capitalist, career, category, CFFT, Chest, Chicago, circumstance, Claremont, Clinton, CNS, coadministration, Colorado, composed, constituting, content, Corixa, Cornell, Crandell, Dartmouth, Deleage, dental, descent, designee, diminution, disability, disabled, disclaim, Distinguishing, division, Drucker, dyspnea, Egan, English, Entrepreneurship, EPS, equitable, EU, exempt, explanatory, extraordinary, FACP, Faraday, Fellow, FileNo, forfeited, Genocea, Genzyme, Georgetown, Graduate, heightened, hereof, Hobart, Holy, home, Homology, hypersensitivity, IIb, Immunex, indefinite, infusion, inhibitor, inventor, Iora, IP, Ironwood, Iwicki, ix, joined, joining, Kala, Keith, kinase, Kindex, Koch, Kythera, leader, leadership, LeukoSite, lifetime, lifted, Liposome, Loyola, Lycera, MA, Madauder, Marina, MBA, membership, Mereo, Millennium, Momenta, Munshi, mycobacterium, Mylotarg, Nelsen, Nephrology, NextCode, ninety, nominee, nonprofit, nonqualified, older, Oncofactor, oncology, onset, oversaw, Oxeia, Park, PCAOB, people, Percivia, persistent, Peter, phantom, PhaseRx, Philosophy, phosphorylation, Physiology, Procept, Pulmazole, Pulmocide, Quantum, Raad, rata, reacquire, Reed, refractory, regranted, regular, repriced, residency, respivert, Riverside, Roach, Rock, SAB, Saga, School, scientist, Sea, Sepracor, Shire, specialty, statutorily, steroid, Stonehill, subdivided, subdivision, Sunovion, surrendered, Synta, Ted, tendered, Thayer, theForm, Theraclone, Thunderbird, Trevena, triazole, Trubion, Tuck, USA, VBI, Vectura, VentiRX, venture, Veristat, vi, vii, viii, viral, Voyager, Walter, Wehave, Women, Wyeth, xi, xii, xiii, xiv
Removed:
acceleration, accumulation, acid, acquirer, Alimi, alter, announced, antibiotic, Barry, Bayer, begin, branded, call, CEO, CFO, children, clinically, commenced, commencing, Concurrent, consecutive, Dawson, derived, deterioration, divided, drop, ease, ending, executed, forma, founded, genetic, Harish, HOCl, Hojabr, Honig, identifiable, indemnification, interpreted, IPO, morbidity, operated, originally, page, parent, partnership, pioneering, practical, primary, proportionally, quotient, repaid, resale, retroactively, RTGN, Rule, Sameer, settled, split, surviving, thick, tied, timeframe, tract, underwriter, unissued, vivo
Filing tables
Filing exhibits
Related press release
PULM similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements of Pulmatrix, Inc. on FormsS-3 (File Nos.333-212546) and FormsS-8 (File Nos.333-195737,333-205752,333-207002,333-212547 and333-216628) of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated March 13, 2018, with respect to our audits of the consolidated financial statements of Pulmatrix, Inc. as of December 31, 2017 and 2016 and for the years then ended, appearing in the Annual Report on Form10-K of Pulmatrix, Inc. for the year ended December 31, 2017.
/s/ Marcum LLP
Marcum LLP
New York, NY
March 13, 2018